MARÍA JESÚS OSET GASQUE-rekin lankidetzan egindako argitalpenak (7)

2023

  1. The activation of mGluR4 rescues parallel fiber synaptic transmission and LTP, motor learning and social behavior in a mouse model of Fragile X Syndrome

    Molecular autism, Vol. 14, Núm. 1, pp. 14

2020

  1. Neuroprotection by phytoestrogens in the model of deprivation and resupply of oxygen and glucose in vitro: The contribution of autophagy and related signaling mechanisms

    Antioxidants, Vol. 9, Núm. 6, pp. 1-20

2019

  1. The loss of β adrenergic receptor mediated release potentiation in a mouse model of fragile X syndrome

    Neurobiology of Disease, Vol. 130

2016

  1. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 122, pp. 326-338

  2. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 118, pp. 178-192

2015

  1. Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease

    Future Medicinal Chemistry, Vol. 7, Núm. 7, pp. 845-855

2014

  1. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9, 10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 74, pp. 491-501